Research Topics
| V WatersSummaryAffiliation: The Hospital for Sick Children Country: Canada Publications
| Collaborators |
Detail Information
Publications
Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosisValerie Waters
Department of Pediatrics, Division of Infectious Diseases, Hospital for Sick Children, Toronto, Canada
Cochrane Database Syst Rev 11:CD009528. 2012..Therefore, choosing antibiotics based on biofilm rather than conventional antimicrobial susceptibility testing could potentially improve response to treatment of Pseudomonas aeruginosa in people with cystic fibrosis...
Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosisValerie Waters
Department of Pediatrics, Division of Infectious Diseases, Hospital for Sick Children, Toronto, Canada
Cochrane Database Syst Rev 12:CD010004. 2012....
Comparison of three typing methods for Pseudomonas aeruginosa isolates from patients with cystic fibrosisV Waters
Division of Infectious Diseases, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, 555 University Avenue, Toronto, Ontario, M5G 1X8, Canada
Eur J Clin Microbiol Infect Dis 31:3341-50. 2012..aeruginosa isolates from CF patients. MLST had the greatest predictive value in identifying strains as unique and, thus, has the potential to be a cost-efficient, high-throughput, first-pass typing method...
Effect of pulmonary exacerbations on long-term lung function decline in cystic fibrosisValerie Waters
Division of Infectious Diseases, Hospital for Sick Children, 555 University Avenue, Toronto, ON, M5G 1X8, Canada
Eur Respir J 40:61-6. 2012..Time between exacerbations, specifically ≤ 6 months between exacerbations, plays an important contribution to overall lung function decline. These findings support using time to next exacerbation as a clinical end-point for CF trials...
Chronic Stenotrophomonas maltophilia infection and exacerbation outcomes in cystic fibrosisValerie Waters
Division of Infectious Diseases, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, 555 University Avenue, Toronto, Canada M5G 1X8
J Cyst Fibros 11:8-13. 2012..The aim of this study was to determine the effect of chronic S. maltophilia infection and associated antimicrobial therapy on the recovery of forced expiratory lung volume in 1s (FEV(1)) following pulmonary exacerbation...
New treatments for emerging cystic fibrosis pathogens other than PseudomonasValerie Waters
Division of Infectious Diseases, Hospital for Sick Children, 555 University Avenue, Toronto, Ontario M5G 1X8, Canada
Curr Pharm Des 18:696-725. 2012....
Live viral vaccines in a DiGeorge syndrome patientV Waters
Department of Pediatrics, Division of Infectious Diseases, Hospital for Sick Children, University of Toronto, Toronto, Canada
Arch Dis Child 92:519-20. 2007..Although live viral vaccines have been used safely in some children with DiGeorge syndrome, there are insufficient data to recommend their routine use in those with severe immunodeficiency...
Outbreak of atypical pertussis detected by polymerase chain reaction in immunized preschool-aged childrenValerie Waters
Division of Infectious Diseases, Department of Pediatrics, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada
Pediatr Infect Dis J 28:582-7. 2009..A case-control study in children was done to identify the risk factors for being positive for Bordetella pertussis by polymerase chain reaction (PCR)...
Stenotrophomonas maltophilia in cystic fibrosis: serologic response and effect on lung diseaseValerie Waters
Division of Infectious Diseases, Department of Pediatrics, Hospital for Sick Children, Toronto, ON, Canada
Am J Respir Crit Care Med 183:635-40. 2011..maltophilia infection on CF lung disease is unknown...
